Barrett’s Esophagus & Esophageal Adenocarcinoma can run in Families
Dr. Amitabh Chak of Case Western Reserve, the leading authority on Familial Links in Barrett’s and EAC, joins ECAN President and CEO Mindy Mintz Mordecai for a look at what the research shows and where he hopes the research will take us in the future.
Recorded April 21, 2020
Surgery & Survival in Esophageal Cancer
Dr. Stephen Yang, The Arthur B. and Patricia B. Modell Professor in Thoracic Surgery and medical oncology at Johns Hopkins Medicine and a founding Board member of the Esophageal Cancer Action Network joins ECAN CEO Mindy Mintz Mordecai for a look at Surgery and Survival in Esophageal Cancer. Dr. Yang provides an overview of the latest techniques for Esophageal Cancer surgery and answers participants’ questions.
Recorded April 22, 2020
The Latest in Treatment for Esophageal Cancer
Dr. A. Craig Lockhart, Chief of Medical Oncology, Sylvester Comprehensive Cancer Center, Miami, FL, and Dr. Sarbajit Muhkerjee, Gastrointestinal Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, provide an overview of the latest treatment options available for patients diagnosed with Esophageal Cancer – and answer questions from ECAN President and CEO Mindy Mintz Mordecai and ECAN supporters.
Recorded April 24, 2020
Preventing Esophageal Cancer: Diagnosing and Treating Barrett’s Esophagus
ECAN Board Member Dr. Sri Komanduri, Medical Director, GI Lab, Director of Interventional Endoscopy, Northwestern University, Chicago discusses the latest methods for the diagnosis and treatment of Barrett’s Esophagus.
Recorded April 28, 2020
Addressing GERD without Pills: Durable Approaches to Acid Reflux
Join ECAN’s Board Chair Dr. John C. Lipham, the Director of the Hoag-USC Foregut Cancer Program at the Keck Medical Center of the University of Southern California in Los Angeles, for a look at surgical approaches to reflux including fundoplication, LINX, and other newer approaches designed to produce a long-term impact on Gastroesophageal Reflux Disease (GERD).
Recorded April 30, 2020
Immunotherapy in Esophageal Cancer
Join Dr. Daniel Catenacci, Director of the Interdisciplinary Gastrointestinal Oncology Program at the University of Chicago Medical Center. We’ll discuss immunotherapy in Esophageal Cancer and what may be possible in the future – and hopefully answer your questions.
Recorded May 11, 2020
What Causes Barrett’s Esophagus to Become Esophageal Cancer?
Join Dr. Matthew Stachler, Principle Investigator and Molecular Genetic Pathologist at the University of California, San Francisco. We’ll discuss the latest discoveries about why Barrett’s becomes Cancer and the implications for prevention, early detection, and more effective treatment – and hopefully, answer your questions.
Recorded June 25, 2020
Check back later for webinar updates!